Dark Forest Capital Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
8,237
-1,757
-18% -$257K 0.1% 367
2026
Q1
$972K Sell
9,994
-13,464
-57% -$1.36M 0.09% 375
2025
Q4
$1.87M Buy
+23,458
New +$1.54M 0.09% 416
2025
Q3
Sell
-89,617
Closed -$3.3M 1438
2025
Q2
$3.3M Buy
+89,617
New +$3.44M 0.13% 237
2023
Q3
Sell
-23,162
Closed -$620K 1286
2023
Q2
$620K Buy
+23,162
New +$568K 0.06% 532
2022
Q4
Sell
-2,444
Closed -$48K 1440
2022
Q3
$48K Buy
2,444
+2,355
+2,646% +$51.8K 0.01% 525
2022
Q2
$2K Sell
89
-29,264
-100% -$570K ﹤0.01% 740
2022
Q1
$749K Buy
29,353
+28,274
+2,620% +$615K 0.18% 167
2021
Q4
$27K Buy
+1,079
New +$30.4K 0.01% 587
2021
Q3
Sell
-47
Closed -$1K 1505
2021
Q2
$1K Buy
+47
New +$1.64K ﹤0.01% 791

Other funds holding RVMD

Dark Forest Capital Management's RVMD Position: Q2 2026 in Review

Dark Forest Capital Management reduced its Revolution Medicines (RVMD) stake by 18% in Q2 2026, selling an estimated $257K and leaving 8,237 shares worth $1.54M. The position accounts for 0.1% of the portfolio, ranked #367.

Dark Forest Capital Management first reported a position in RVMD in Q2 2021 and has held it in 10 quarters since. The position peaked at $3.3M in Q2 2025. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Dark Forest Capital Management held 8,237 shares of Revolution Medicines worth $1.54M as of Q2 2026.
  • Dark Forest Capital Management sold 1,757 Revolution Medicines shares in Q2 2026, an estimated $257K.
  • Revolution Medicines made up 0.1% of Dark Forest Capital Management's portfolio in Q2 2026, its #367 holding.
  • Dark Forest Capital Management first reported a position in Revolution Medicines in Q2 2021 and has held it in 10 quarters since.
  • Dark Forest Capital Management's Revolution Medicines position peaked at $3.3M in Q2 2025.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.